Accomplished Consumer Goods and Health Care Leader Would Bring Decades of Leadership Experience to Role EAGLE, Idaho, Feb. 11, 2025 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”), a leading pet medication, health and wellness company and portfolio company of Bansk Group, is pleased to announce that Camillo Pane would join PetIQ as Chief Executive Officer, effective February 17, 2025. Mr. Pane would succeed Cord... Read More

EAGLE, Idaho and NEW YORK, Oct. 25, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, health and wellness company, today announced the successful completion of its acquisition by Bansk Group (“Bansk”), a consumer-focused private investment firm dedicated to building distinctive consumer brands, in an all-cash transaction valued at approximately $1.5 billion. PetIQ... Read More

EAGLE, Idaho, Oct. 22, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, health and wellness company, announced today that at its virtual Special Meeting of Stockholders approximately 80% of its outstanding shares of common stock voted to approve the adoption of the definitive merger agreement (the “Agreement”) pursuant to which Bansk Group will acquire all of the... Read More

EAGLE, Idaho, and NEW YORK, New York, Aug. 07, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, health and wellness company, and Bansk Group (“Bansk”), a consumer-focused private investment firm dedicated to building distinctive consumer brands, today announced that PetIQ entered into a definitive agreement (the “Agreement”) pursuant to which Bansk Group will acquire... Read More

Generates Record Second Quarter 2024 Net Sales and Net Income Record Adjusted EBITDA of $39.0 Million Exceeds Company's Second Quarter 2024 Guidance PetIQ and Bansk Group Sign Definitive Merger Agreement EAGLE, Idaho, Aug. 07, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, product and wellness company, today reported financial results for the second quarter and six... Read More

EAGLE, Idaho, July 17, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, health and wellness company, today announced it will report financial results for the second quarter and six months ended June 30, 2024, on Wednesday, August 7, 2024, after the market close. The Company will host a conference call with members of the executive management team to discuss these... Read More

EAGLE, Idaho, June 05, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, product and wellness company, today announced that members of its executive management team will participate in the Oppenheimer 24th Annual Consumer Growth and E-Commerce Conference. A virtual fireside chat will be available on Tuesday, June 11, 2024 at 10:30 a.m. EDT. The live webcast and replay... Read More

Reports Record First Quarter 2024 Net Sales of $308.4 Million Achieves Record First Quarter Net Income Record Adjusted EBITDA Exceeds Company's First Quarter 2024 Guidance Raises Full Year 2024 Outlook EAGLE, Idaho, May 08, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, product and wellness company, today reported financial results for the first quarter ended March... Read More

EAGLE, Idaho, April 22, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, health and wellness company, today announced it will report financial results for the first quarter ended March 31, 2024, on Wednesday, May 8, 2024, after the market close. The Company will host a conference call with members of the executive management team to discuss these results. The... Read More

EAGLE, Idaho, March 14, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, product, and wellness company, has announced the launch of Minties ® dental treats for large-sized dogs, expanding the Minties ® brand to now include affordable, veterinarian-recommended dental... Read More

EAGLE, Idaho, March 07, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, product and wellness company, has officially kicked off flea & tick season with NextStar, ® the fastest-acting 30-day topical protection available,* to help educate pet parents on year-round monthly... Read More

Record Full Year 2023 Net Sales Increase 19.6% Year-Over-Year to Over $1.1 Billion Adjusted EBITDA Exceeds Company's Full Year 2023 Guidance Reports Highest Annual Cash from Operations in the Company's History of $61.9 Million Provides First Quarter 2024 and Full Year 2024 Outlook EAGLE, Idaho, Feb. 28, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, product and... Read More

EAGLE, Idaho, Feb. 07, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report financial results for the fourth quarter and full year ended December 31, 2023, on Wednesday, February 28, 2024, after the market close. The Company will host a conference call with members of the executive management team to discuss these... Read More

EAGLE, Idaho, Dec. 20, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, has announced the launch of the Portable Calming Diffuser for Dogs and Cats from its SENTRY ® Calming line of pet care products just in time to help pets feel calm and relaxed... Read More

Record Third Quarter 2023 Net Sales Increase 32% to $277.0 Million Net Sales and Adjusted EBITDA Exceed Company's Third Quarter 2023 Guidance Highest Year-to-Date Cash from Operations in the Company's History of $64.7 Million Announces Services Segment Optimization Raises 2023 Annual Outlook EAGLE, Idaho, Nov. 07, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and... Read More

EAGLE, Idaho, Oct. 17, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report financial results for the third quarter ended September 30, 2023, on Tuesday, November 7, 2023, after the market close. The Company will host a conference call with members of the executive management team to discuss these results. The conference... Read More

Record Second Quarter 2023 Net Sales Increase 25% to $314.5 Million Net Sales and Adjusted EBITDA Exceeds Company's Second Quarter 2023 Guidance Record Second Quarter Cash from Operations of $57.7 Million Raises 2023 Annual Outlook EAGLE, Idaho, Aug. 08, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today reported financial results for the... Read More

EAGLE, Idaho, Aug. 02, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced that John Pearson, who has served as the Company’s Senior Vice President, Head of Services since 2022, has been appointed Executive Vice President, Services & Manufactured Products, a newly created role, effective August 2, 2023. In his new role, Pearson will... Read More

EAGLE, Idaho, July 20, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report financial results for the second quarter ended June 30, 2023, on Tuesday, August 8, 2023, after the market close. The Company will host a conference call with members of the executive management team to discuss these results. The conference call... Read More

EAGLE, Idaho, June 01, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced members of the management team will participate in two upcoming June investor conferences. Wednesday, June 7, 2023 -- William Blair 43rd Annual Growth Stock Conference: The presentation is scheduled for 8:00 a.m. Eastern Time. Tuesday, June 13, 2023 --... Read More

Reports First Quarter 2023 Net Sales of $290.5 Million Achieves Record Quarterly Net Income Record Quarterly Adjusted EBITDA Exceeds Company's First Quarter 2023 Guidance Reiterates 2023 Annual Outlook EAGLE, Idaho, May 09, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today reported financial results for the first quarter ended March 31, 2023.... Read More

EAGLE, Idaho, April 18, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report financial results for the first quarter ended March 31, 2023, on Tuesday, May 9, 2023, after the market close. The Company will host a conference call with members of the executive management team to discuss these results. The conference call is... Read More

Full Year 2022 Net Sales and Adjusted EBITDA In-Line with Company Guidance Updates Adjusted EBITDA Methodology Reports Record Annual Cash from Operations of $48.0 Million Completes Complementary, Margin Accretive Acquisition of Rocco & Roxie Provides First Quarter 2023 and Full Year 2023 Outlook EAGLE, Idaho, Feb. 28, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and... Read More

EAGLE, Idaho, Jan. 31, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report financial results for the fourth quarter and full year ended December 31, 2022, on Tuesday, February 28, 2023, after the market close. The Company will host a conference call with members of the executive management team to discuss these results.... Read More